Imperial and BASF spinout SOLVE to digitally transform chemical manufacturing.
CDT rEaCt Cohort 1 student, Dr Linden Schrecker, has successfully launched his own spinout company, SOLVE, which aims to use AI to improve the manufacturing of drugs and fertilisers.
About SOLVE
Sponsored by BASF, Dr Schrecker completed his PhD at Imperial College London, where he developed transient flow methodology and worked on academic and industrial examples while developing new data-rich methods.
Dr Schrecker worked with CDT rEaCt Director's Professor Mimi Hii from the Department of Chemistry, and Professor Klaus Hellgardt from the Department of Chemical Engineering.
He and the team recognized the potential to start a company centered on solvent replacement, a critical need in the chemical industry. However, the industry had less data than expected, opening up opportunities for us to provide broader support. Expanding the original focus and enhanced its efficiency by incorporating machine learning methods.
SOLVE will offer its services to a range of clients from across the chemical and pharmaceutical industries.
The interdisciplinary nature of the CDT rEaCt was foundational to developing the technology behind SOLVE (spanning chemistry, chemical engineering and machine learning) and also for learning how to communicate across disciplines to build an effective multidisciplinary team. Dr Linden Schrecker Founder and CEO, Solve
Support
SOLVE in the news
Find out more
Visit the SOLVE website for further information